Your browser doesn't support javascript.
loading
Bacterial neuraminidase inhibitory chalcones from flowers of Coreopsis lanceolata, their kinetic characterization and antibiofilm effect.
Lee, Seung Hwan; Baiseitova, Aizhamal; Moon, Si Won; Im, Se Young; Park, Ki Hun.
Afiliación
  • Lee SH; Division of Applied Life Science (BK21 Four), IALS, Gyeongsang National University, Jinju 52828, Republic of Korea.
  • Baiseitova A; Division of Applied Life Science (BK21 Four), IALS, Gyeongsang National University, Jinju 52828, Republic of Korea.
  • Moon SW; Division of Applied Life Science (BK21 Four), IALS, Gyeongsang National University, Jinju 52828, Republic of Korea.
  • Im SY; Division of Applied Life Science (BK21 Four), IALS, Gyeongsang National University, Jinju 52828, Republic of Korea.
  • Park KH; Division of Applied Life Science (BK21 Four), IALS, Gyeongsang National University, Jinju 52828, Republic of Korea. Electronic address: khpark@gnu.ac.kr.
Phytomedicine ; 130: 155789, 2024 Jul 25.
Article en En | MEDLINE | ID: mdl-38824826
ABSTRACT

BACKGROUND:

Bacteria within biofilms are thousand times more resistant to antibiotics. Neuraminidase is a crucial enzyme for bacterial adhesion and biofilm formation, it hydrolyzes glycosidic residue of glycoproteins, glycolipids, and oligosaccharides. Coreopsis lanceolata L. flowers may have a significant potential of bacterial neuraminidase (BNA) inhibition because of high natural abundance of chalcones.

PURPOSE:

The investigation of bacterial biofilm inhibitors has emerged as a novel therapeutic strategy against antibiotic resistance. Therefore, individual chalcones were isolated from C. lanceolata and their capacity to inhibit BNA and formation of Escherichia coli biofilm were evaluated.

METHODS:

Different chromatographic techniques were used to isolate the compounds (1-12). Enzyme inhibition and detailed kinetic behavior of compounds was determined by estimation of kinetic parameters (Michaelis-Menten constants (Km), maximum velocity (Vmax), dissociation constant for binding with the free enzyme (KI) and enzyme-substate complex (KIS)). Binding affinities (KSV) and binding modes of inhibitors were elucidated by fluorescence quenching and molecular docking, respectively. The natural abundance of chalcones was established through UPLC-Q-TOF/MS. The most potent inhibitor (1) was tested for its ability to inhibit the formation of E. coli biofilm, which was examined by crystal violet assay, scanning electron microscope (SEM) and confocal laser scanning microscope (CLSM).

RESULTS:

A series of eight chalcones (1-8) and four chalcone glucosides (9-12), inhibited BNA in a dose-dependent manner with IC50 of 8.3 ∼ 77.0 µM. The most potent chalcones were butein (1, IC50 = 8.3 µM) and its glucoside 9 (IC50 = 13.8 µM). The aglycones (1-8) showed non-competitive inhibition, while chalcone glucosides (9-12) displayed a mixed type I (KI < KIS). Inhibitory behaviors were doubly confirmed by KSV and matched with tendency of IC50. The functional group responsible for BNA inhibition were disclosed as 4'-hydroxyl group on B-ring by structure activity relationship (SAR) and molecular docking experiments. Butein (1) suppressed E. coli biofilm formation by > 50 % at 100 µM according to crystal violet assay, which was confirmed by SEM and CLSM imaging.

CONCLUSION:

The results showed that chalcones (1-8) and chalcone glucosides (9-12), metabolites isolated from the flowers of C. lanceolata, had BNA inhibitory and antibiofilm formation effect on E. coli.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biopelículas / Coreopsis / Flores / Chalconas / Escherichia coli / Antibacterianos / Neuraminidasa Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biopelículas / Coreopsis / Flores / Chalconas / Escherichia coli / Antibacterianos / Neuraminidasa Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2024 Tipo del documento: Article